Minimizing adverse experience associated with oxybutynin therapy

Details for Australian Patent Application No. 2001253782 (hide)

Owner Watson Pharmaceuticals, Inc

Inventors Sanders, Steven W.; Ebert, Charles D.

Agent FB Rice

Pub. Number AU-B-2001253782

PCT Pub. Number WO01/80796

Priority 09559711 26.04.00 US

Filing date 24 April 2001

Wipo publication date 7 November 2001

Acceptance publication date 29 June 2006

International Classifications

A61F 13/00 (2006.01) Bandages, dressings or absorbent pads

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 31/216 (2006.01)

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/14 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

Event Publications

29 June 2006 Application Accepted

  Published as AU-B-2001253782

26 October 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001253783

2001253781